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Abstract
To succed in gene therapy it is necessary to observe few basic conditions, such as targeted
delivery of the therapeutic gene into the target organ and its effective expression. Nowadays
targeted delivery of therapeutic genes is one of the critical problems of gene therapy. Delivery
of  recombinant  genes  using cell  carriers  (vectors),  expressing tissue-specific  cell  adhesion
molecules, allows us to move toward solving this problem. Using Gateway cloning technology
(Invitrogen) we have created recombinant expression constructs pAd-NCAM1, pAd-NCAM2 and
pAd-L1CAM, encoding neural cell adhesion molecules. Expression of recombinant proteins has
been confirmed by immunofluorescent analysis. Based on these genetic constructs recombinant
adenoviruses (serotype 5) were generated and titered. Obtained viral vectors encoding neural
cell  adhesion  molecules  may  be  subsequently  used  to  modify  cells  carrying  additional
therapeutic genes to increase the efficiency of gene-cell therapeutics delivery to target organ.
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